Representing Shareholders, Employees, and Consumers for Over 30 Years
MiMedx_logo_CMYK.png

News

News & Investigations

News and Investigations

We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.

 

Microchip Executives Under Investigation for Possible Breaches of Fiduciary Duties

1.jpeg

Schubert Jonckheer & Kolbe is investigating potential shareholder derivative claims on behalf of stockholders of Microchip Technology Inc. (NASDAQ: MCHP) related to the company’s statements to shareholders and the market concerning its 2018 merger with Microsemi Corporation.

Microchip is a chip manufacturer headquartered in Chandler, Arizona. On March 1, 2018, Microchip announced its intent to acquire Microsemi, another chip manufacturer, for $10.15 billion, and the transaction closed on May 29, 2018. On August 9, 2018, Microchip announced that it had discovered substantial inventory in Microsemi’s distribution channel, substantially reducing the company’s net free cash flow and its ability to rapidly service debt assumed to pay for the merger. These disclosures caused a substantial decline in the price of Microchip stock, and a securities class action lawsuit was promptly filed on behalf of damaged investors in federal court in Arizona. By order dated March 11, 2020, the motion to dismiss the securities class action lawsuit was denied in part. The court held that the complaint alleged with sufficient particularity that the defendants made false and misleading statements to the market related to Microsemi’s inventory, and that they did so with scienter, or intent to defraud investors.

We are investigating potential derivative claims based on harm the company has suffered as a result of potential breaches of fiduciary duty by the company’s officers and directors.

If you currently own Microchip stock and wish to obtain additional information—or would like to participate in a potential shareholder derivative action—please complete the form below for a free legal consultation.